China NMPA Product Recall - Vanguard PS open-box femoral condyle prosthesis

Biomet Orthopedics, operating through its Chinese entities Bangmei (Shanghai) Trading Co., Ltd. and Zimmer Biomet (Shanghai) Medical International Trading Co., Ltd., initiated a Level II voluntary recall for specific batches of its Vanguard PS open-box femoral condyle prostheses. The core issue, identified during the period of April 5, 2016, to September 1, 2016, originated from inadequate supplier clearance procedures. This procedural lapse resulted in incorrect product packaging labels, misstating the size (smaller or larger) and/or side (right/left) of the knee joint components.

This recall was reported to the National Medical Products Administration (NMPA), adhering to the regulatory framework outlined in the "Medical Device Recall Event Report Form CFDA (Imported) No. 2014" and "National Food and Drug Administration Medical Device Approval No. 2014" in China. Globally, 3301 affected units were identified, with 2322 units having been sold in China.

Despite a low estimated incidence rate of 0.001% and no recorded adverse events or complaints in China, Biomet Orthopedics took proactive measures. The required action involved the recall of all unused affected products, which have since been successfully returned to the manufacturer. The company provided comprehensive details regarding the affected models and batch numbers to facilitate the recall process and ensure patient safety.